Cargando…

Radiopharmaceuticals for Cancer Imaging and Therapy

Detalles Bibliográficos
Autores principales:	Bormans, Guy, Cleeren, Frederik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537697/ https://www.ncbi.nlm.nih.gov/pubmed/37765231 http://dx.doi.org/10.3390/pharmaceutics15092262

Ejemplares similares

3p-C-NETA: A versatile and effective chelator for development of Al(18)F-labeled and therapeutic radiopharmaceuticals
por: Ahenkorah, Stephen, et al.
Publicado: (2022)

D-Peptide-Based Probe for CXCR4-Targeted Molecular Imaging and Radionuclide Therapy
por: Luyten, Kaat, et al.
Publicado: (2021)

PET Radiopharmaceuticals
por: Shahhosseini, Soraya
Publicado: (2011)

Are we “preparing” radiopharmaceuticals?
por: Decristoforo, Clemens, et al.
Publicado: (2016)

Can we produce an image of bacteria with radiopharmaceuticals?
por: Signore, A., et al.
Publicado: (2008)

Pharmaceuticals—Special Issue on Radiopharmaceutical Chemistry between Imaging and Endoradiotherapy
por: Kopka, Klaus
Publicado: (2014)

Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside
por: Ahenkorah, Stephen, et al.
Publicado: (2021)

The present status of radiopharmaceuticals in the country
por: Jalilian, Amir Reza, et al.
Publicado: (2016)

Radiopharmaceuticals for therapy
por: Knapp, F F (Russ), et al.
Publicado: (2016)

Greetings from the New President of World Association of Radiopharmaceutical and Molecular Therapy
por: Srivastava, Suresh
Publicado: (2016)

Greetings from the New President of the World Association of Radiopharmaceutical and Molecular Therapy
por: Virgolini, Irene
Publicado: (2018)

Metal-Based Radiopharmaceuticals in Inorganic Chemistry
por: Boschi, Alessandra, et al.
Publicado: (2023)

Nomenclature for radiopharmaceuticals, consultation of your opinion!
por: Elsinga, Philip H.
Publicado: (2017)

Use of imaging-based dosimetry for personalising radiopharmaceutical therapy of cancer
por: Beauregard, Jean-Mathieu
Publicado: (2022)

Micro-flow photosynthesis of new dienophiles for inverse-electron-demand Diels–Alder reactions. Potential applications for pretargeted in vivo PET imaging
por: Billaud, Emilie M. F., et al.
Publicado: (2017)

Position statement on radiopharmaceutical production for clinical trials
por: Bormans, G., et al.
Publicado: (2017)

Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy
por: Everix, Liesbeth, et al.
Publicado: (2023)

A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma
por: Bolcaen, Julie, et al.
Publicado: (2021)

The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma
por: Dizdarevic, S, et al.
Publicado: (2019)

Automated GMP compliant production of [(18)F]AlF-NOTA-octreotide
por: Tshibangu, Térence, et al.
Publicado: (2020)

Radiopharmaceutical tracers for cardiac imaging
por: Manabe, Osamu, et al.
Publicado: (2017)

Improved Detection of Molecular Markers of Atherosclerotic Plaques Using Sub-Millimeter PET Imaging
por: Bridoux, Jessica, et al.
Publicado: (2020)

Development of Superparamagnetic Nanoparticles Coated with Polyacrylic Acid and Aluminum Hydroxide as an Efficient Contrast Agent for Multimodal Imaging
por: González-Gómez, Manuel Antonio, et al.
Publicado: (2019)

Radiopharmaceutical therapy in cancer: clinical advances and challenges
por: Sgouros, George, et al.
Publicado: (2020)

Radiopharmaceuticals in Nuclear Medicine: Recent Developments for SPECT and PET Studies
por: Gutfilen, Bianca, et al.
Publicado: (2014)

Positron emission tomography: Evolving modalities, radiopharmaceuticals and professional collaboration
por: Ayesa, Sally L., et al.
Publicado: (2022)

CXCR4-Targeted Radiopharmaceuticals for the Imaging and Therapy of Malignant Tumors
por: Yu, Jingjing, et al.
Publicado: (2023)

Al(18)F-Labeling Of Heat-Sensitive Biomolecules for Positron Emission Tomography Imaging
por: Cleeren, Frederik, et al.
Publicado: (2017)

Radiopharmaceuticals in monitoring cancer
por: Britton, Keith E., et al.
Publicado: (2015)

Stroma Targeting Nuclear Imaging and Radiopharmaceuticals
por: Shetty, Dinesh, et al.
Publicado: (2012)

Radiopharmaceuticals for PET imaging: issue A
por: Roivainen, Anne, et al.
Publicado: (2020)

The new Regulation on clinical trials in relation to radiopharmaceuticals: when and how will it be implemented?
por: Peñuelas, Iván, et al.
Publicado: (2019)

Optimizing the Safety and Efficacy of Bio-Radiopharmaceuticals for Cancer Therapy
por: Funeh, Cyprine Neba, et al.
Publicado: (2023)

Special Issue “Targets, Tracers and Translation Novel Radiopharmaceuticals Boost Nuclear Medicine”
por: Reischl, Gerald
Publicado: (2019)

Update on PET Radiopharmaceuticals for Imaging Hepatocellular Carcinoma
por: Nyakale, Nozipho, et al.
Publicado: (2023)

Cerenkov Luminescence Tomography for In Vivo Radiopharmaceutical Imaging
por: Zhong, Jianghong, et al.
Publicado: (2011)

(64)Cu-based Radiopharmaceuticals in Molecular Imaging
por: Zhou, Yeye, et al.
Publicado: (2019)

PET Radiopharmaceuticals for Imaging Chemotherapy-Induced Cardiotoxicity
por: Sivapackiam, Jothilingam, et al.
Publicado: (2020)

Pharmacovigilance in radiopharmaceuticals
por: Kumar, Rishi, et al.
Publicado: (2016)

Radiolabeling of Human Serum Albumin With Terbium-161 Using Mild Conditions and Evaluation of in vivo Stability
por: Cassells, Irwin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8cd51odgbsvork8q8hqu0oc193